- Home
- GOSS vs IDR Comparison
GOSS vs IDR Comparison
Compare GOSS & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- IDR
- Stock Information
- Founded
- GOSS 2015
- IDR 1996
- Country
- GOSS United States
- IDR United States
- Employees
- GOSS N/A
- IDR N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- GOSS Health Care
- IDR Basic Materials
- Exchange
- GOSS Nasdaq
- IDR Nasdaq
- Market Cap
- GOSS 347.8M
- IDR 378.0M
- IPO Year
- GOSS 2019
- IDR N/A
- Fundamental
- Price
- GOSS $1.96
- IDR $25.51
- Analyst Decision
- GOSS Strong Buy
- IDR Strong Buy
- Analyst Count
- GOSS 4
- IDR 1
- Target Price
- GOSS $8.50
- IDR $17.50
- AVG Volume (30 Days)
- GOSS 3.2M
- IDR 479.3K
- Earning Date
- GOSS 08-05-2025
- IDR 08-07-2025
- Dividend Yield
- GOSS N/A
- IDR N/A
- EPS Growth
- GOSS N/A
- IDR 57.55
- EPS
- GOSS N/A
- IDR 0.64
- Revenue
- GOSS $40,237,000.00
- IDR $30,496,328.00
- Revenue This Year
- GOSS N/A
- IDR $21.91
- Revenue Next Year
- GOSS $63.97
- IDR $5.47
- P/E Ratio
- GOSS N/A
- IDR $39.96
- Revenue Growth
- GOSS N/A
- IDR 59.64
- 52 Week Low
- GOSS $0.66
- IDR $9.58
- 52 Week High
- GOSS $2.23
- IDR $27.39
- Technical
- Relative Strength Index (RSI)
- GOSS 58.35
- IDR 71.70
- Support Level
- GOSS $1.67
- IDR $23.11
- Resistance Level
- GOSS $2.00
- IDR $27.39
- Average True Range (ATR)
- GOSS 0.17
- IDR 1.54
- MACD
- GOSS -0.02
- IDR 0.56
- Stochastic Oscillator
- GOSS 52.21
- IDR 83.41
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.